The new chemistry, called Sprq, improves flow cell sample loading and incorporates a new polymerase to augment sequencing yield and reduce per-sample costs.
Broad Institute and Northwestern University researchers are encouraging others to examine noncoding genes, when investigating undiagnosed rare diseases.
Bio-Rad Revenue Growth 'Back to Normal' as Firm Postpones Integrated Digital PCR Launch Indefinitely
Premium
Bio-Rad confirmed its full-year guidance, reflecting a slower gradual pace of biopharma end market recovery and growth for the clinical diagnostics group.
The company's instrument revenue was $19.1 million, down 46 percent year over year, while consumables revenue totaled $126.2 million, up 10 percent year over year.
Illumina's Dragen Outperforms Broad GATK, Google DeepVariant in Variant Analysis Benchmarking Study
Premium
Illumina's latest Dragen pipeline brings pangenome-based variant analysis to the masses, though the change will be invisible to most users.